| 1 | What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
| ADAI/UW Link |
| 2 | The impact of changing nicotine replacement therapy licensing laws in the United Kingdom: findings from the International Tobacco Control Four Country Survey.
| UW Link |
| 3 | A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
| ADAI/UW Link |
| 4 | Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study.
| ADAI/UW Link |
| 5 | Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
| ADAI/UW Link |
| 6 | A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.
| ADAI/UW Link |
| 7 | Progressive reduction using nicotine gum as a prelude to quitting.
| ADAI/UW Link |
| 8 | Beliefs and attitudes about bupropion: Implications for medication adherence and smoking cessation treatment.
| UW Link |
| 9 | Adverse reaction to nicotine gum in Malay female smoker: a case report.
| UW Link |
| 10 | Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum.
| UW Link |
| 11 | Disparities in access to over-the-counter nicotine replacement products in New York City pharmacies.
| UW Link |
| 12 | Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.
| UW Link |
| 13 | Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
| ADAI/UW Link |
| 14 | Use of nicotine substitute prescribed at hourly intake and ad libitum or ad libitum for heavy smokers willing to quit: a randomized controlled trial.
| Free Link |
| 15 | An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.
| UW Link |
| 16 | Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness.
| UW Link |
| 17 | Transdermal nicotine administration and the electroencephalographic activity of substance abusers in treatment.
| UW Link |
| 18 | The impact of a free nicotine patch starter kit on quit rates in a state quit line.
| ADAI/UW Link |
| 19 | Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial.
| UW Link |
| 20 | The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy.
| UW Link |
| 21 | Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance.
| UW Link |
| 22 | Psychological mediators of bupropion sustained-release treatment for smoking cessation.
| UW Link |
| 23 | Significance of off-label use of NRT.[nicotine replacement therapy]
| UW Link |
| 24 | Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.
| UW Link |
| 25 | Use of nicotine replacement therapy among never smokers in the 1999-2006 National Health and Nutrition Examination Surveys.
| UW Link |
| 26 | Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
| UW Link |
| 27 | A placebo-controlled trial of modafinil for nicotine dependence.
| UW Link |
| 28 | Open-label study of craving in smokers with schizophrenia using nicotine nasal spray compared to nicotine patch.
| ADAI/UW Link |
| 29 | The Fagerstrom test for nicotine dependence and its relationship to NRT use and readiness-to-quit.
| ADAI/UW Link |
| 30 | Over-the-counter nicotine replacement therapy: Can its impact on smoking cessation be enhanced?
| UW Link |
| 31 | Motivational and behavioral factors predicting success in cigarette smoking-cessation treatment combining group therapy with bupropion.
| ADAI/UW Link |
| 32 | Preliminary study of buprenorphine and bupropion for opioid-dependent smokers.
| ADAI/UW Link |
| 33 | Sex differences in long-term smoking cessation rates due to nicotine patch.
| ADAI/UW Link |
| 34 | A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
| ADAI/UW Link |
| 35 | Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers.
| ADAI/UW Link |
| 36 | Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
| UW Link |
| 37 | Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.
| ADAI/UW Link |
| 38 | Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
| ADAI/UW Link |
| 39 | The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation.
| ADAI/UW Link |
| 40 | A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
| ADAI/UW Link |
| 41 | Exercise as an adjunct to nicotine gum in treating tobacco dependence among women.
| ADAI/UW Link |
| 42 | Nicotine patch therapy prior to quitting smoking: a meta-analysis.
| UW Link |
| 43 | Pharmaceutical aids for quitting nicotine. . . Is it all just smoke and mirrors?
Schmidt SN
J Addict Nurs 2008;19(1):39 (Journal) [ ] | ADAI/UW Link |
| 44 | Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation.
| UW Link |
| 45 | Smoking cessation pharmacotherapy preferences in rural primary care.
| ADAI/UW Link |
| 46 | Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
| UW Link |
| 47 | A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.
| UW Link |
| 48 | Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials.
| ADAI/UW Link |
| 49 | Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
| ADAI/UW Link |
| 50 | Smokers' interest in using nicotine replacement to aid smoking reduction.
| ADAI/UW Link |
| 51 | Treating smokers before the quit date: Can nicotine patches and denicotinized cigarettes reduce cravings?
| ADAI/UW Link |
| 52 | Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: A randomized controlled trial.
| UW Link |
| 53 | Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden.
| UW Link |
| 54 | Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts.
| UW Link |
| 55 | The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline.
| UW Link |
| 56 | Offering free NRT through a tobacco quitline: impact on utilisation and quit rates.
| UW Link |
| 57 | Expanding access to nicotine replacement therapy through Minnesota's QUITLINE partnership.
| UW Link |
| 58 | Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking.
| UW Link |
| 59 | Efficacy of bupropion alone and in combination with nicotine gum.
| ADAI/UW Link |
| 60 | Does free nicotine replacement therapy for young adults prompt them to call a quitline?
| UW Link |
| 61 | Bupropion and cognitive-behavioral treatment for depression in smoking cessation.
| ADAI/UW Link |
| 62 | Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.
| ADAI/UW Link |
| 63 | A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
| UW Link |
| 64 | Bupropion SR for the treatment of smokeless tobacco use.
| UW Link |
| 65 | Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
| UW Link |
| 66 | Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
| UW Link |
| 67 | The effects of exercise and nicotine replacement therapy on smoking rates in women.
| UW Link |
| 68 | Nicotine percentage replacement among smokeless tobacco users with nicotine patch.
| UW Link |
| 69 | Bupropion and cognitive-behavioral therapy for smoking cessation in women.
| ADAI/UW Link |
| 70 | The Cochrane review on nicotine replacement therapy: incorrect or uncertain classifications of additional support levels.
| UW Link |
| 71 | A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers.
| UW Link |
| 72 | The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis.
| UW Link |
| 73 | Use of more nicotine lozenges leads to better success in quitting smoking.
| UW Link |
| 74 | Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline.
| ADAI/UW Link |
| 75 | Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge.
| UW Link |
| 76 | Cognitive behavioral therapy and nicotine replacement for smoking cessation in psychiatric outpatients with major depression.
Hill KP ; Chang G
Addict Disorders Treat 2007;6(2):67-72 (Journal) [ ] | UW Link |
| 77 | Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men.
| ADAI/UW Link |
| 78 | Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
| ADAI/UW Link |
| 79 | Nicotine lozenges for the treatment of smokeless tobacco use.
| ADAI/UW Link |
| 80 | The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.
| ADAI/UW Link |
| 81 | Physicians' counseling of patients when prescribing nicotine replacement therapy.
| UW Link |
| 82 | Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study.
| UW Link |
| 83 | Transdermal nicotine for smoking cessation in postmenopausal women.
| UW Link |
| 84 | Changes in markers of epithelial permeability and inflammation in chronic smokers switching to a nonburning tobacco device (Eclipse).
| ADAI/UW Link |
| 85 | Barriers and motivators to gaining access to smoking cessation services amongst deprived smokers - a qualitative study.
| UW Link |
| 86 | Recruiting pregnant smokers for a placebo-randomised controlled trial of nicotine replacement therapy.
| UW Link |
| 87 | Looking for boomerang effects: A pre-post experimental study of the effects of exposure of youth to television advertising for nicotine replacement therapy and Zyban (R).
| UW Link |
| 88 | Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.
| ADAI/UW Link |
| 89 | Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial.
| UW Link |
| 90 | Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial.
| ADAI/UW Link |
| 91 | Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial.
| ADAI/UW Link |
| 92 | Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy.
| UW Link |
| 93 | Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.
| UW Link |
| 94 | The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design.
| UW Link |
| 95 | Adolescent smokers screened for a nicotine replacement treatment trial: correlates of eligibility and enrollment.
| ADAI/UW Link |
| 96 | Attitudes and knowledge about nicotine and nicotine replacement therapy.
| ADAI/UW Link |
| 97 | A randomised-controlled pilot study using nicotine patches with pregnant women.
| UW Link |
| 98 | Response to Perkins and Scott. Nicotine patch and lozenge are effective for women.
| ADAI/UW Link |
| 99 | Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
| ADAI/UW Link |
| 100 | High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.
| UW Link |
| 101 | Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
| UW Link |
| 102 | Developments in pharmacotherapy for tobacco dependence: past, present and future.
| UW Link |
| 103 | Drug counselor report of adolescents’ abuse of nicotine replacement therapy.
| ADAI/UW Link |
| 104 | Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.
| ADAI/UW Link |
| 105 | Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats.
| ADAI/UW Link |
| 106 | Precessation treatment with nicotine skin patch facilitates smoking cessation.
| ADAI/UW Link |
| 107 | Effects on smoking cessation: naltrexone combined with a cognitive behavioral treatment based on the community reinforcement approach.
| ADAI/UW Link |
| 108 | Smoking during pregnancy versus no smoking and using nicotine replacement therapies (NRT); a critical review of an article.
Einarson A
J FAS Int 2006;4:e4 Feb 2006 (Online resource) [ ] | Free Link |
| 109 | Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving.
| UW Link |
| 110 | Comment on Shiffman and colleagues, "Nicotine patch and lozenge are effective for women."
| ADAI/UW Link |
| 111 | Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
| ADAI/UW Link |
| 112 | The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion.
| ADAI/UW Link |
| 113 | Combination treatment for nicotine dependence: state of the science. [Review]
| ADAI/UW Link |
| 114 | Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.
| ADAI/UW Link |
| 115 | When California smokers use nicotine replacement therapy, most are trying to quit smoking.
| UW Link |
| 116 | Characteristics of selectors of nicotine replacement therapy.
| UW Link |
| 117 | Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death.
| UW Link |
| 118 | A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation.
| ADAI/UW Link |
| 119 | Effect of nicotine replacement therapy on post-cessation weight gain and nutrient intake: a randomized controlled trial of postmenopausal female smokers.
| UW Link |
| 120 | Transdermal nicotine alters some of marihuana's effects in male and female volunteers.
| UW Link |
| 121 | Adverse effects of pharmacological therapy for nicotine addiction in smokers following a smoking cessation program.
| ADAI/UW Link |
| 122 | Does nicotine do what we think it does? A meta-analytic review of the subjective effects of nicotine in nasal spray and intravenous studies with smokers and nonsmokers.
| ADAI/UW Link |
| 123 | Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial.
| ADAI/UW Link |
| 124 | Over-the-counter availability of nicotine replacement therapy and smoking cessation.
| ADAI/UW Link |
| 125 | U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy.
| ADAI/UW Link |
| 126 | Nortriptyline for smoking cessation: a review.
| ADAI/UW Link |
| 127 | Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study.
| ADAI/UW Link |
| 128 | Impact of nicotine replacement therapy on smoking behavior. [review]
| UW Link |
| 129 | Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach.
| UW Link |
| 130 | Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis.
| UW Link |
| 131 | Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy.
| ADAI/UW Link |
| 132 | Nicotine lozenge efficacy in light smokers.
| UW Link |
| 133 | Nicotine replacement therapy use among a cohort of smokers.
| ADAI/UW Link |
| 134 | The effectiveness of nicotine patch and nicotine lozenge in very heavy smokers.
| UW Link |
| 135 | Instructions about nicotine dose influence acute responses to nasal spray.
| ADAI/UW Link |
| 136 | A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler.
| UW Link |
| 137 | Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy.
| UW Link |
| 138 | Use of pharmacy data to evaluate smoking regulations' impact on sales of nicotine replacement therapies in New York City.
| UW Link |
| 139 | Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison.
| UW Link |
| 140 | Naltrexone augments the effects of nicotine replacement therapy in female smokers.
| ADAI/UW Link |
| 141 | Effectiveness of bupropion for smoking cessation during pregnancy.
| ADAI/UW Link |
| 142 | Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy.
| UW Link |
| 143 | Nicotine patch and lozenge are effective for women.
| ADAI/UW Link |
| 144 | Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion.
| ADAI/UW Link |
| 145 | Offering telephone counseling to smokers using pharmacotherapy.
| ADAI/UW Link |
| 146 | Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers.
| UW Link |
| 147 | Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
| UW Link |
| 148 | Clinical utility of the combination of cognitive-behavioral techniques with nicotine patches as a smoking-cessation treatment: five-year results of the “Ex-Moker” program.
| UW Link |
| 149 | Transdermal nicotine use in postmenopausal women: does the treatment efficacy differ in women using and not using hormone replacement therapy?
| ADAI/UW Link |
| 150 | Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis.
| ADAI/UW Link |
| 151 | A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women.
| UW Link |
| 152 | Effects of different nicotine replacement therapies on postcessation psychological responses.
| UW Link |
| 153 | Psychotic symptoms associated with bupropion treatment for smoking cessation.
| ADAI/UW Link |
| 154 | Correlates of adherence with transdermal nicotine.
| UW Link |
| 155 | The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program.
| UW Link |
| 156 | GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
| UW Link |
| 157 | Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR.
| UW Link |
| 158 | Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
| UW Link |
| 159 | Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia.
| ADAI/UW Link |
| 160 | Pretreatment with transdermal nicotine enhances some of ethanol's acute effects in men.
| UW Link |
| 161 | Pharmacotherapy for smoking cessation during pregnancy. [Review]
| ADAI/UW Link |
| 162 | Smokers' expectancies for nicotine replacement therapy vs. cigarettes.
| ADAI/UW Link |
| 163 | Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments
| ADAI/UW Link |
| 164 | Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
| ADAI/UW Link |
| 165 | Recruiting pregnant smokers for a placebo-randomised controlled trial of nicotine replacement therapy.
| UW Link |
| 166 | Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes.
| UW Link |
| 167 | The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials.
| UW Link |
| 168 | Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking.
| ADAI/UW Link |
| 169 | Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample.
| ADAI/UW Link |
| 170 | Tolerability and pharmacokinetics of single and repeated doses of nicotine with The Straw, a novel nicotine replacement product.
| ADAI/UW Link |
| 171 | A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
| ADAI/UW Link |
| 172 | Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
| ADAI/UW Link |
| 173 | Level of nicotine replacement during a quit-smoking attempt.
| ADAI/UW Link |
| 174 | Do small lapses predict relapse to smoking behavior under bupropion treatment?
| ADAI/UW Link |
| 175 | Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
| UW Link |
| 176 | Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use.
| UW Link |
| 177 | The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.
| UW Link |
| 178 | Naltrexone and nicotine patch smoking cessation: a preliminary study.
| ADAI/UW Link |
| 179 | Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
| ADAI/UW Link |
| 180 | Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
| ADAI/UW Link |
| 181 | Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD?
| UW Link |
| 182 | Do mobile phones replace cigarette smoking among teenagers?
| UW Link |
| 183 | Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample.
| UW Link |
| 184 | A randomised clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents.
| UW Link |
| 185 | Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence.
| UW Link |
| 186 | Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking.
| UW Link |
| 187 | Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy.
| UW Link |
| 188 | The effect of nicotine patch therapy on depression in nonsmokers: a preliminary study.
| ADAI/UW Link |
| 189 | Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome.
| UW Link |
| 190 | A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation.
| UW Link |
| 191 | Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up.
| UW Link |
| 192 | Does menthol attenuate the effect of bupropion among African American smokers?
| UW Link |
| 193 | Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
| ADAI/UW Link |
| 194 | Treatment of adolescent smokers with the nicotine patch.
| ADAI/UW Link |
| 195 | Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling.
| UW Link |
| 196 | Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
| ADAI/UW Link |
| 197 | Pharmacokinetics of a nicotine polacrilex lozenge.
| ADAI/UW Link |
| 198 | Efficacy of nicotine patch in smokers with a history of alcoholism.
| UW Link |
| 199 | Impact of messages on concomitant use of nicotine replacement therapy and cigarettes: a randomized trial on the Internet.
| UW Link |
| 200 | Review of bupropion for smoking cessation.
| UW Link |
| 201 | Pharmacotherapies to enhance smoking cessation during pregnancy.
| UW Link |
| 202 | Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone.
| UW Link |
| 203 | High levels of transdermal nicotine exposure produce green tobacco sickness in Latino farmworkers.
| ADAI/UW Link |
| 204 | The demand for nicotine replacement therapies.
| ADAI/UW Link |
| 205 | Naltrexone treatment for alcoholics: Effect on cigarette smoking rates.
| ADAI/UW Link |
| 206 | Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence.
| ADAI/UW Link |
| 207 | Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males.
| ADAI/UW Link |
| 208 | Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting.
| ADAI/UW Link |
| 209 | Effects of the nicotine patch on performance during the first week of smoking cessation.
| ADAI/UW Link |
| 210 | Smoking cessation, smoking reduction, and delayed quitting among smokers given nicotine patches and a self-help pamphlet.
| ADAI/UW Link |
| 211 | Interest in nicotine replacement therapy among pregnant smokers. [letter]
| UW Link |
| 212 | Eclipse: does it live up to its health claims?
| UW Link |
| 213 | A meta-analysis of the efficacy of over-the-counter nicotine replacement.
| UW Link |
| 214 | Subsidised nicotine replacement therapy. [letter]
| UW Link |
| 215 | Estimating the health consequences of replacing cigarettes with nicotine inhalers.
| UW Link |
| 216 | The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials.
| ADAI/UW Link |
| 217 | Prolonged nicotine patch use in quitters with past abstinence-induced depressed mood.
| UW Link |
| 218 | Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch.
| ADAI/UW Link |
| 219 | Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: a comparison of postmenopausal women using and not using hormone replacement therapy.
| ADAI/UW Link |
| 220 | Role of naltrexone in initial smoking cessation: preliminary findings.
| UW Link |
| 221 | Pharmacotherapy for alcoholic smokers.
| UW Link |
| 222 | Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care.
| ADAI/UW Link |
| 223 | Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting.
| ADAI/UW Link |
| 224 | Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review.
| ADAI/UW Link |
| 225 | Efficacy of over-the-counter nicotine patch.
| ADAI/UW Link |
| 226 | Eclipse can deliver crack cocaine.
| ADAI/UW Link |
| 227 | Pharmacotherapy for smoking cessation.
Goldstein MG
In: Abrams DB ; Niaura R ; Brown RA ; Emmons KM ; Goldstein MG ; Monti PM. THE TOBACCO DEPENDENCE TREATMENT HANDBOOK : A GUIDE TO BEST PRACTICES. New York : The Guilford Press, 2003, pp.230-248 (Chapter) [Call No: RC 567 T634 2003] [ ] | |
| 228 | Be wary of subsidizing nicotine replacement therapy.
| UW Link |
| 229 | Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
| ADAI/UW Link |
| 230 | Effects of a low dose of transdermal nicotine on information processing.
| ADAI/UW Link |
| 231 | Focus groups with pregnant smokers: barriers to cessation, attitudes to nicotine patch use and perceptions of cessation counselling by care providers.
| UW Link |
| 232 | Mediating mechanisms for the impact of bupropion in smoking cessation treatment.
| UW Link |
| 233 | Effect of non-nicotinic moist snuff replacement and lobeline on withdrawal symptoms during 48-h smokeless tobacco deprivation.
| ADAI/UW Link |
| 234 | Real-world efficacy of prescription and over-the-counter nicotine replacement therapy.
| UW Link |
| 235 | Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status.
| UW Link |
| 236 | Regulation of nicotine replacement therapies (NRT): a critique of current practice. [Review]
| UW Link |
| 237 | Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. [Review]
| UW Link |
| 238 | Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.
| UW Link |
| 239 | A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
| ADAI/UW Link |
| 240 | The effectiveness of over-the-counter nicotine replacement : a rebuttal.
Hughes JR
Drug Alcohol Rev 2001;20(3):319-322 (Journal) [ ] | UW Link |
| 241 | The effectiveness of nicotine replacement therapy over-the-counter : reply to Hughes.
| UW Link |
| 242 | Are higher doses of nicotine replacement more effective for smoking cessation?
| ADAI/UW Link |
| 243 | Long-term effects of nicotine gum on weight gain after smoking cessation.
| ADAI/UW Link |
| 244 | Commentaries on the effectiveness of over-the-counter nicotine replacement.
| UW Link |
| 245 | Nicotine replacement methods on a psychiatric unit.
| ADAI/UW Link |
| 246 | The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy.
| UW Link |
| 247 | Multimodal assessment of the effect of chewing gum on nicotine withdrawal.
| UW Link |
| 248 | Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.
| ADAI/UW Link |
| 249 | Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
| ADAI/UW Link |
| 250 | Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program.
| ADAI/UW Link |
| 251 | Efficacy of the nicotine patch for relief of craving and withdrawal 7-10 weeks after cessation.
| ADAI/UW Link |
| 252 | Tolerability of concurrent use of nicotine gum and smoking in healthy volunteers.
| ADAI/UW Link |
| 253 | Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving.
| UW Link |
| 254 | Nicotine patches improve mood and response speed in a lexical decision task.
| UW Link |
| 255 | Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit.
| UW Link |
| 256 | Cigarette consumption and sales of nicotine replacement products.
| UW Link |
| 257 | Smoking cessation activities by general practitioners and practice nurses.
| UW Link |
| 258 | Relationships between sensation seeking and emotional symptomatology during smoking cessation with nicotine patch therapy.
| UW Link |
| 259 | Computer tailored intervention for older smokers using transdermal nicotine.
| UW Link |
| 260 | The use of pharmacotherapies for smoking cessation during pregnancy.
| UW Link |
| 261 | Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample.
| ADAI/UW Link |
| 262 | A critical evaluation of nicotine replacement therapy for teenage smokers.
Patten CA
J Child Adolesc Subst Abuse 2000;9(4):51-75 (Journal) [ ] | ADAI/UW Link |
| 263 | Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle.
| ADAI/UW Link |
| 264 | Effects of nicotine gum does by level of nicotine dependence.
| ADAI/UW Link |
| 265 | Nicotine replacement therapies and beyond.
Westman EC ; Rose JE
In: Piasecki M ; Newhouse PA (eds.). NICOTINE IN PSYCHIATRY : PSYCHOPATHOLOGY AND EMERGING THERAPEUTICS. Washington, DC : American Psychiatric Press, Inc., 2000, pp.215-233 (Chapter) [Call No: RC 567 N5237 2000] [ ] | |
| 266 | The effectiveness of nicotine replacement therapy over-the-counter.
| UW Link |
| 267 | The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
|